On February 3, 2016, a motion for a protective order/to file a pleading under seal was filed in the bankruptcy case of KaloBios Pharmaceuticals, Inc. and its affiliates.
The filing was assigned docket number 131 and is described on the court’s official docket as follows:
Motion to File Under Seal Exhibit to the Declaration of Dr. Cameron Durrant in Support of Debtor’s Opposition to United States Trustee’s Emergency Motion for an Order Directing the Appointment of a Trustee or, in the Alternative, Conversion to a Chapter 7 Case Filed by Kalobios Pharmaceuticals, Inc.. Hearing scheduled for 2/4/2016 at 10:00 AM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #2, Wilmington, Delaware. (Attachments: # (1) Exhibit A) (McLaughlin, Marcy)
KaloBios Pharmaceuticals, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 29, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-12628. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Morris, Nichols, Arsht & Tunnell LLP is acting as lead bankruptcy counsel to KaloBios Pharmaceuticals, Inc. in the bankruptcy case.